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ABSTRACT 
For seven weeks, 37 overweight adults followed a hypocaloric diet based on Orthodox 
Fasting (OF). A hypocaloric, time restricted eating (TRE) plan (eating between 08:00 
to 16:00h, water fasting from 16:00 to 08:00h) was followed by 23 Body Mass Index 
(BMI)-matched participants. Anthropometric, glycaemic and inflammation markers 
and serum lipids were assessed before and after the diets. Both OF and TRE groups 
demonstrated reductions in BMI (28.54 ± 5.45 vs 27.20 ± 5.10 kg/m2, p<0.001 and 
26.40 ± 4.11 vs 25.81 ± 3.78 kg/m2 p=0.001, respectively). Following the intervention, 
the OF group presented lower concentrations of total and low-density lipoprotein-
cholesterol, compared with the pre-fasting values (178.40 ± 34.14 vs 197.17 ± 34.30 
mg/dl, p<0.001 and 105.89 ± 28.08 vs 122.37 ± 29.70 mg/dl, p<0.001, respectively). 
Neither group manifested significant differences in glycaemic and inflammatory 
parameters. Our findings suggest that OF has superior lipid lowering effects than the 
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Introduction 
Accumulating evidence suggests the Mediterranean Diet (MD) as an ideal nutritional 
model for the prevention of cardiometabolic diseases, including diabetes mellitus (DM) 
and coronary artery disease (CAD) (Keys et al. 1986; Prinelli et al. 2015). In contrast, 
western-pattern diets, containing large amounts of saturated fatty acids (SFA) and 
leading to increased visceral adiposity have resulted in an increasing prevalence of 
cardiometabolic diseases worldwide, which is expected to become even greater within 
the next decades (Caputo et al. 2017; Mendola et al. 2018). The contribution of limited 
physical activity to the obesity pandemic should be also considered, albeit its impact is 
not well-defined and might be less crucial than that traditionally believed (Muller and 
Soares 2019). In any case, the complex interactions between genetic, dietary and life-
style factors that determine the development of the disorder render the establishment of 
causal associations challenging. 
Orthodox religious fasting (OF) comprises a variation of the typical MD, where fasting 
and non-fasting periods alternate during the calendar year. It is deeply integrated in the 
dietary behaviour of Orthodox Christians and is followed by a large proportion of the 
Orthodox population for prolonged periods (from 120 to 180 days) annually (Persynaki 
et al. 2017). This nutritional advocacy has been shown to integrate characteristics that 
promote cardiovascular (CV) health, including energy restriction and optimal effects 
on lipid concentrations (Sarri et al. 2004). Athonian monks, residing in the monastic 
community of Athos in Northern Greece, practice a pescatarian OF variation in which 
meat consumption is not allowed during either fasting or non-fasting days. We have 
previously demonstrated that the Athonian fasting is characterised by lower energy 
intake than the typical OF, thus resulting in optimal anthropometric profiles and low 
insulin resistance among the monks (Karras et al. 2017, 2019).  
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Ramadan is an alternative type of complete, intermittent, religious fasting that involves 
no calorie restriction (CR). Ramadan fasters refrain from eating and drinking during 
the daytime, whereas food consumption is allowed from sunset to dawn. Although the 
effects of this type of fasting on the metabolism of lipids, proteins and carbohydrates 
remain debatable, chronobiological studies have linked Ramadan with changes in 
circadian distribution of body temperature, cortisol, melatonin and blood glucose levels 
(Roky et al 2004). Accordingly, decreased nocturnal sleep, daytime alertness and 
psychomotor performance have been reported among Ramadan fasters (Afifi 1997).  
Alternative dietary models have been recently shown to promote human health and are 
gaining popularity worldwide. In this context, intermittent fasting (IF) is a nutritional 
pattern characterised by periodical abstinence from eating (Varady and Hellerstein 
2007). Different types of IF can be found in the literature: a) time restricted eating 
(TRE), in which eating is allowed during a specific time-window of the day, i.e. 8 hours 
followed by fasting for the remaining 16 hours of the day (Tinsley and Paoli 2019). 
Typically, this dietary plan does not involve CR during the time period of eating. b) 
periodic fasting, in which fasting is practiced for up to 24 hours for specific days of the 
week with ad libitum (ad lib) food intake for the remaining days and c) alternate-day 
fasting (ADF), in which ad lib food intake and fasting days (<25% of total energy 
needs) alternate during the week, with some ADF protocols suggesting no food intake 
on fast days (Barnosky et al. 2014).   
 Despite the great variability in terms of forms and practices, existing studies are 
generally pointing towards favourable effects of IF on body composition and CV risk 
factors, through a variety of mechanisms (Rothschild et al. 2014). However, the clinical 
implications of such dietary models are still under investigation (Varady and 
Hellerstein 2007; Barnosky et al. 2014; Rothschild et al. 2014). 
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Up to now, studies investigating the effects of OF and IF on human health are limited. 
The aim of the present study was to comparatively evaluate the effects of two different 
nutritional plans on glycaemic, lipid and anthropometric profiles of overweight adults: 
the Athonian OF, a vegetarian advocacy of continuous energy restriction versus a 
hybrid model of combined CR and TRE, assessing their suitability as diets for the 
promotion of optimal cardiometabolic health. 
 
Materials and methods  
Study population 
Participants were employees of the AHEPA University Hospital and the Aristotle 
University of Thessaloniki, Greece and were recruited between December 1, 2018 and 
February 28, 2019 via advertisements in the university and the hospital websites.  
Exclusion criteria were: i) presence of chronic kidney disease, severe liver disease, 
prediabetes / DM or uncontrolled hypothyroidism (not adequately controlled or firstly 
diagnosed and receiving no treatment), ii) recent surgical operations or infections, iii) 
treatment with agents affecting body weight (BW), glucose metabolism and lipid 
profile (statins, corticosteroids, antipsychotics), iv) consumption of vitamins or mineral 
supplements, vi) physical disabilities and/or neurodegenerative diseases that could 
affect physical activity and vii) acute infections and chronic degenerative diseases. 
 
Dietary intervention 
Individuals that were regularly practicing OF for many consecutive years due to 
spiritual beliefs were selected to participate in the OF group and the rest of participants 
were assigned to the TRE group. The intervention period lasted seven weeks (48 days) 
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and took place during Lent fasting, preceding Orthodox Easter (March and April, 
2019). Both groups followed a hypocaloric diet, providing a total of 1200-1500 
kilocalories (kcal) [(5020.8-6276 kilojoules (kJ)] per day for women and 1500-1800 
kcal (6276-7531.2 kJ) per day for men. Their daily energy requirements were calculated 
based on their daily basal metabolic rate, adjusted for an expected weight loss of ≥ 0.5 
kilogram (kg) per week (energy deficit of 500-750 kcal / 2092-3138 kJ per week) and 
estimated according to the equations provided by the AHA recommendations for the 
management of overweight and obesity (Jensen et al. 2014).  
TRE individuals were asked to eat from 08:00 to 16:00 h daily, and fast from 16:00 to 
08:00 h daily. During the 8-h eating window, participants were advised to follow their 
given dietary plans, consisted of two meals (08:00 and 13:00h) and two snacks (11:00 
and 15:30h). During the fasting period, subjects were free to consume water and 
energy-free beverages, such as tea, coffee, and sodas. The OF group followed a dietary 
plan based on the principles of Athonian fasting and abstained from consuming animal 
products (meat, poultry, fish, eggs, dairy and cheese), with the exception of two days 
during the fasting period, when fish were allowed.  
The recommended amounts from each food group in OF and TRE groups were decided 
according to the standards of the Greek Orthodox Church fasting practice (Karras et al. 
2017, 2019) and the United States (US) Department of Agriculture Dietary Guidelines 
(The Healthy US Style Eating Pattern) (U.S. Department of Health and Human Services 
and U.S. Department of Agriculture 2015) and the Greek National Dietary Guidelines 
for Adults (Greek National…2014), respectively. Adherence to dietary plans was 
evaluated with a 3-day food record (two weekdays and one weekend day), at the end of 
the study period. The Nutrition Analysis Software Food Processor (ESHA Research 
2018) (Food Processor Analysis Software 2018) was used to analyse the 3-day food 
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records. Dietitians of the research team contacted all participants twice during the 
intervention to confirm their adherence to diets and resolve potential issues. Finally, all 
participants were asked to maintain a stable level of physical activity during the study 
period, defined as 150 minutes per week of moderate-intensity aerobic exercise, 
according to the AHA recommendations (Jensen et al. 2014).  
 
Anthropometric measurements 
Height was measured to the nearest 0.1 centimetre (cm) with a Holtain wall 
stadiometer. Waist circumference (WC) was measured midway between the lowest rib 
and the iliac crest by using an anthropometric tape. BW was recorded to the nearest 
0.01 kg using a calibrated computerised digital balance (K-Tron P1-SR, USA Onrion 
IIc); each participant was barefoot and lightly dressed during measurement.  The Body 
Mass Index (BMI) was calculated as the ratio of weight in kilograms divided by the 
height in meters squared (kg/m2) (World Health Organization 2019). Body fat (BF) 
mass and percentage, muscle mass (MM) and lean body mass (LBM), were measured 
using bioelectrical impedance analysis (BIA) (SC-330 S, Tanita Corporation, Tokyo) 
(Tanita Academy 2019). Anthropometric evaluation was separately performed by two 
investigators (SK and LA).  
 
Biochemical analysis 
Blood samples were drawn in the morning, after a 12-hour overnight fast, one day 
before and following the end of fasting period, by ante-cubital venepuncture and 
samples were stored at -20°C prior to analysis. Fasting glucose (FPG), fasting insulin 
(FPI), serum lipid profile [total cholesterol (TC), high-density lipoprotein cholesterol 
(HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), 
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apolipoprotein A (ApoA) and apolipoprotein B-100 (ApoB-100)] and high sensitivity 
C-reactive protein (hs-CRP) determinations were performed using the system of 
automated analysers COBAS 8000 (D-68298; Roche Diagnostics, Mannheim, 
Germany).  
Reference range of values as well as inter and intra-assay coefficients of variation for 
the examined parameters are as follows: FPG: 70-100 mg/dl, 1.15% and 0.53%, FPI: 
<25 mIU/L, 3.6% and 1.1%, TC: 100-200 mg/dl, 1.5% and 1.6%, HDL-C: >45 mg/dl, 
1.46% and 1.54%, LDL-C: <130 mg/dl: optimal, 130-159 mg/dl: borderline high, 160-
189 mg/dl: high, >190 mg/dl: very high,  TG: <150 mg/dl: normal, 150-199 mg/dl: 
moderately high, 200-499 mg/dl: high, >500 mg/dl: very high, 1.85% and 0.73%, 
ApoA: 104-215 mg/dl, 2.5% and 1.23%, ApoB-100: 63-125 mg/dl, 2.8% and 1.6%, 
and hs-CRP < 0,5mg/dl, 5.25% and 1.0% (Roche Diagnostics 2019).  
Insulin resistance was calculated using the homeostatic model assessment for 
calculating insulin resistance (HOMA-IR) as follows: FPI (µU/ml) x FPG 
(mmol/L)/22.5. Pancreatic beta cell function was calculated using the homeostatic 
model assessment of beta-cell function (HOMA-B), as follows: (20 X FPI)/ (FPG – 
3.5). Both formulae are as described by Matthews et al. (1985), where FPI stands for 




Kolmogorov-Smirnov analysis was carried out on the data to test for normality. Results 
indicated that body fat, triglyceride and energy intake did not meet parametric 
assumptions therefore differences between groups were calculated using Mann-
Whitney U tests. All other parameters were normally distributed. Group differences at 
baseline and after treatment were tested using independent samples t-tests (or Mann-
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Whitney test). Paired sample t-tests were used to compare between anthropometric, 
biochemical and dietary measurements before and after intervention within the OF and 
TRE groups. Mixed model ANOVA was used to assess the interaction effects of diet 
between the groups. For all tests a significance level of p<0.05 was used. Statistical 
analysis was carried out using SPSS version 24 (IBM, Armonk, NY, USA). 
 
Ethical considerations 
All procedures performed in the present study were in accordance with the 1964 
Helsinki declaration and its later amendments. Informed consent was obtained from all 
individual participants included in the study. The research protocol was approved by 




39 individuals were initially screened for inclusion in the OF group. Among them, one 
had a history of treatment with statins and another with metformin and therefore, were 
excluded. One participant opted-out during the study due to being unable to adhere to 
the diet. As a result, data in the OF group were available for 37 individuals (26 female 
/ 11 male, mean age 50.11 ± 8.66 years) at baseline and for 36 persons at the end of the 
study period. The last time these regular fasters had practiced OF for a long period 
before their inclusion in the study, was approximately 3 months ago, during the 
Christmas fasting period (5 weeks); in addition, they were restraining from meat, olive 
oil and dairy products on every Wednesday and Friday throughout the year, according 
to the Orthodox Church rules.  
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24 persons were initially screened for inclusion in the TRE group. One was excluded 
due to history of antidiabetic treatment and one opted-out during the study for personal 
reasons. Data in the TRE group were available for 23 participants (17 female / 6 male, 




Mean daily energy intake among Orthodox fasters at baseline was 1535.5 ± 176.3 kcal 
(6424.5 ± 737.6 kJ) and at the end of the study was 1648.5 ± 278.3 kcal (6897.3 ± 
1164.4 kJ). The dietary macronutrient distribution in this group was 45-55% [of total 
daily energy intake (TEI)] carbohydrates, 10-20% protein and 30-40% fat.  
The dietary macronutrient distribution in the TRE group was 52-55% (of TEI) 
carbohydrates, 15-18% protein and 30% fat. Mean daily energy intake for the TRE 
group at baseline was 1579.3 ± 154.0 kcal (6607.7 ± 644.3 kJ) and at the end of the 
study was 1718.9 ± 285.2 kcal (7191.9 ± 1193.3 kJ), being not different from the 
respective energy intake of Orthodox fasters (p=0.130). Table 1 presents the diet 
composition and macronutrients distribution in both groups at baseline and at the end 
of the study. 
 
Body composition and anthropometric measurements 
Before and after OF 
At the end of the fasting period, Orthodox fasters demonstrated significant reductions 
in BW (75.94 ±15.74 vs 78.13 ± 16.39 kg, p<0.001), BMI (27.20 ± 5.10 vs 28.54 ± 
5.45 kg/m2, p<0.001) and WC (90.30 ± 13.91 vs 91.10 ± 13.88 cm, p=0.036), compared 
with pre-fasting values. No significant differences before and after the fasting were 
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noticed with respect to LBM (47.51 ± 9.91 vs 46.75 ± 11.03 kg, p=0.362), BF (29.32 ± 
14.14 vs 28.30 ± 12.68 kg, p=0.186) and MM (48.80 ± 9.76 vs 47.94 ± 10.84 kg, 
p=0.212). Table 2 presents the comparisons between features of the OF group, before 
and after fasting.  
 
Before and after TRE 
Following the diet, participants in the TRE group demonstrated significant reductions 
in BW (70.48 ± 11.73 vs 72.04 ± 12.54 kg, p=0.001), BMI (25.81 ± 3.78 vs 26.40 ± 
4.11 kg/m2, p=0.001) and WC (84.09 ± 9.57 vs 86.13 ± 10.66 cm, p=0.009), compared 
with their pre-diet values.  No significant differences before and after the intervention 
were observed regarding LBM (50.54 ± 12.77 vs 49.06 ± 15.57 kg, p=0.412) and MM 
(48.76 ± 9.85 vs 48.49 ± 9.61 kg, p=0.330). In contrast, BF mass was significantly 
lower after the diet (22.01 ± 7.32 vs 23.05 ± 7.61 kg, p=0.001). Table 3 presents the 
comparisons between features of the TRE group, before and after the diet. 
 
Interactions 
At baseline, Orthodox fasters and the TRE group presented comparable BW (78.13 ± 
16.39 vs 72.04 ± 12.54 kg, p=0.120), BMI (28.54 ± 5.45 vs 26.40 ± 4.11 kg/m2, 
p=0.098), WC (91.10 ± 13.88 vs 86.13 ± 10.66 cm, p=0.143), LBM (47.51 ± 9.91 vs 
50.54 ± 12.77  kg, p=0.341), BF (29.32 ± 14.14 vs 23.05 ± 7.61 kg, p=0.132) and MM 
(48.80 ± 9.76 vs 48.76 ± 9.85 kg, p=0.989) values. Table 4 presents the comparisons 
between baseline features of the two groups.  
Following the dietary intervention, Orthodox fasters and the TRE group did not differ 
with respect to BW (75.94 ± 15.74 vs 70.48 ± 11.73 kg, p=0.159), BMI (27.20 ± 5.10 
vs 25.81 ± 3.78 kg/m2, p=0.110), LBM (46.75 ± 11.08 vs 49.06 ± 15.57 kg, p=0.301), 
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BF (28.30 ± 12.68 vs 22.01 ± 7.32 kg, p=0.150) and MM (47.94 ± 10.84 vs 48.49 ± 
9.61 kg, p=0.848) values. In contrast, the TRE group presented lower WC values (84.09 
± 9.57 vs 90.30 ± 13.91 cm, p=0.049) than the OF group.  Table 5 presents the 
comparisons between features of the two groups, following the intervention.  
 
Blood parameters 
Before and after OF 
Participants in the OF group manifested lower TC (178.40 ± 34.14 vs 197.17 ± 34.30 
mg/dl, p<0.001), HDL-C (51.01 ± 11.66 vs 53.91 ± 12.31 mg/dl, p=0.009) and LDL-C 
(105.89 ± 28.08 vs 122.37 ± 29.70 mg/dl, p<0.001) concentrations after the diet, 
compared with their pre-diet values. In contrast, ApoA and ApoB-100 concentrations 
did not present significant differences before and after the fasting (146.79 ± 23.70 vs 
142.56 ± 23.42 mg/dl, p=0.133 and 98.44 ± 27.01 vs 96.73 ± 26.60 mg/dl, p=0.554, 
respectively). FPG (84.23 ± 7.96 vs 85.17 ± 9.53 mg/dl, p=0.554), FPI (10.08 ± 7.46 
vs 9.98 ± 9.00 μΙU/ml, p=0.927), HOMA-B (193.01 ± 134.43 vs 168.36 ± 124.11, 
p=0.293), HOMA-IR (2.14 ± 1.69 vs 2.12 ± 1.98, p=0.923) and hs-CRP (0.24 ± 0.25 
vs 0.23 ± 0.54 mg/dl, p=0.885) values did not present significant changes before and 
following the fasting (Table 2).  
 
Before and after TRE 
In the TRE group, TC (201.26 ± 28.41 vs 197.09 ± 29.61 mg/dl, p=0.286), ApoA 
(164.91 ± 28.09 vs 158.52 ± 26.85 mg/dl, p=0.140) and ApoB-100 (107.00 ± 20.43 vs 
107.26 ± 22.24 mg/dl, p=0.902) concentrations remained unchanged before and after 
the diet. In contrast, participants manifested higher TG (90.26 ± 26.78 vs 81.71 ± 29.07 
mg/dl, p=0.036) and lower HDL-C concentrations (60.13 ± 15.93 vs 64.04 ± 16.72 
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mg/dl, p=0.023) at the end of the intervention, compared with their baseline values. 
FPG (87.48 ± 9.96 vs 83.52 ± 8.94 mg/dl, p=0.087), FPI (11.33 ± 16.01 vs 8.08 ± 4.88 
μΙU/ml, p=0.344), HOMA-B (126.22 ± 58.64 vs 163.72 ± 104.59, p=0.059), HOMA-
IR (1.80 ± 1.11 vs 1.72 ± 1.15, p=0.781) and hs-CRP (0.12 ± 0.11 vs 0.20 ± 0.25 mg/dl, 
p=0.077) values did not present significant changes before and following the fasting 
(Table 3).  
 
Interactions 
At baseline, TC (197.17 ± 34.30 vs 201.26 ± 28.41 mg/dl, p=0.548), LDL-C (122.37 ± 
29.70 vs 120.87 ± 28.74 mg/dl, p=0.945) and ApoB-100 (98.44 ± 27.01 vs 107.00 ± 
20.43 mg/dl, p=0.219) concentrations did not differ significantly between the OF and 
the TRE group. In contrast, the OF group manifested higher TG (102.80 ± 45.54 vs 
81.71 ± 29.07 mg/dl, p=0.026) and lower HDL-C (53.91 ± 12.31 vs 64.04 ± 16.72 
mg/dl, p=0.008) and ΑpoA (146.79 ± 23.70 vs 164.91 ± 28.09 mg/dl, p=0.008) 
concentrations, compared with the TRE subjects. FPG (84.23 ± 7.96 vs 87.48 ± 9.96 
mg/dl, p=0.221), FPI (10.08 ± 7.46 vs 11.33 ± 16.01 μΙU/ml, p=0.909), HOMA-IR 
(2.14 ± 1.69 vs 1.80 ± 1.11, p=0.209) and hs-CRP (0.24 ± 0.25 vs 0.12 ± 0.11 mg/dl, 
p=0.075) values did not significantly differ between the OF and the TRE group. The 
HOMA-B index was lower in the TRE than the OF group (126.22 ± 58.64 vs 193.01 ± 
134.43, p=0.022) (Table 4).  
Following the intervention, Orthodox fasters had lower TC (178.40 ± 34.14 vs 197.09 
± 29.61 mg/dl, p=0.028), HDL-C (51.01 ± 11.66 vs 60.13 ± 15.93 mg/dl, p=0.013) and 
ApoA (142.56 ± 23.42 vs 158.52 ± 26.85 mg/dl, p=0.019) levels, compared with TRE 
participants. ApoB-100 concentrations were comparable between the groups (96.73 ± 
26.60 vs 107.26 ± 22.24 mg/dl, p=0.106). FPG (85.17 ± 9.53 vs 83.52 ± 8.94 mg/dl, 
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p=0.576), FPI (9.98 ± 9.00 vs 8.08 ± 4.88 μΙU/ml, p=0.378), HOMA-B (168.36 ± 
124.11 vs 163.72 ± 104.59, p=0.854), HOMA-IR (2.12 ± 1.98 vs 1.72 ± 1.15, p=0.415) 
and hs-CRP (0.23 ± 0.54 vs 0.20 ± 0.25 mg/dl, p=0.835) values did not significantly 
differ between the OF and the TRE group (Table 5).  
 
Discussion 
To the best of our knowledge, this is the first study comparatively assessing the effects 
of OF and a different dietary pattern on anthropometric, lipid and glycaemic profiles. 
In addition, ApoA and ApoB-100 concentrations were determined for the first time in 
the present study in a population of Orthodox fasters, before and following the fasting. 
Its originality also lies on the fact that in one of the study groups, TRE and CR were 
combined in the same nutritional plan. The results showed that both OF and the TRE 
diet resulted in improvements in the anthropometric features of the participants, with 
OF also presenting lipid-lowering effects.  
Previously published clinical studies (Sarri et al. 2003; Karras et al. 2017, 2019) and 
systematic reviews (Koufakis et al. 2017) have highlighted the optimal effects of OF 
on blood lipids and more specifically on TC and LDL-C concentrations, which have 
been shown to decline up to 17.8 and 31.4 % respectively, during the fasting periods 
(Koufakis et al. 2018). Potential mechanisms mediating these effects are the decreased 
consumption of SFA, leading to increased number of LDL receptors (Mustad et al. 
1997) and the restriction in energy intake (Koufakis et al. 2018). Similar to other 
vegetarian diets, OF results in a parallel decrease of HDL-C and ApoA concentrations. 
It is well established that HDL-C levels present an adverse association with CV risk 
and that this relationship remains significant even for individuals with very low LDL-
C concentrations (< 70 mg/dl), as those treated with statins (Barter et al. 2007). In a 
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similar way, ApoA levels have been shown to predict recurrent CV events and all-cause 
mortality in secondary prevention studies, suggesting that this biomarker might be 
useful for CV risk estimation in people with CAD (Van Lennep et al. 2000). 
Accumulating evidence suggests that ApoB-100 might be a superior to LDL-C marker 
for assessment of CV risk and its addition to the routine lipid panel to enhance patient 
management has been proposed (Contois et al. 2009). In our study, ApoB-100 levels 
were not found to be affected by the two diets; however, previous reports have proved 
a significant reduction in its concentrations, following a consumption of a defined, 
plant-based diet for 4 weeks (Najjar et al. 2018), as well as during Ramadan fasting 
(Adlouni et al. 1998). 
TG concentrations have been previously shown to increase during fasting (Sarri et al. 
2003; Koufakis et al. 2017, 2018), probably because of increased carbohydrate intake 
(carbohydrate-induced hypertriglyceridemia) (Hudgins 2000). The exact impact of the 
aforementioned lipid changes on vegetarians’ health remains controversial. A recently 
published, large observational study which followed 48188 participants for 18 years, 
showed that fish eaters and vegetarians had lower rates of CAD than meat eaters, 
although vegetarians had higher rates of haemorrhagic and total stroke (Tong et al. 
2019).  
Studies in the field of IF are characterised by significant heterogeneity in terms of 
included population, type of dietary intervention and explored outcomes. However, 
recent works conducted on both animals and humans, have associated IF with optimal 
metabolic outcomes, mediated by changes in hormonal environment, including an 
increase in plasma concentrations of adiponectin and a decrease in leptin and resistin 
levels, optimisation of circadian rhythms and gut microbiome (Melkani and Panda 
2017).  Several studies have proved optimal effects of IF plans on BW and composition. 
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A systematic review and meta-analysis of eleven trials demonstrated that intermittent 
energy restriction was not inferior to the continuous approach, in terms of weight loss 
(− 0.61 kg, 95% CI − 1.70 to 0.47; p = 0.27) (Cioffi et al. 2018). Worth noting, the 
metabolic benefits of IF are not exclusively dependent on reduction in BW. As shown 
in a proof-of-concept study by Sutton et al. (2018), 5 weeks of early TRE (6-hr eating 
period, with dinner before 3 p.m.) improved beta-cell responsiveness, insulin 
sensitivity, blood pressure, oxidative stress, and appetite, irrespectively of weight loss 
in people with prediabetes.  
Similar to our observations, Gabel et al. (2018), did not prove a significant reduction in 
plasma lipids and glycaemic parameters in obese adults, following an 8-h TRE plan for 
12 weeks, despite an achieved weight loss of approximately 2.6%. Moro et al. (2016), 
investigated the impact of a 16/8 TRE pattern on body composition, inflammation and 
CV risk factors in resistance-trained individuals. Although a decrease in fat mass was 
observed in the TRE compared with the control group (p=0.04), no significant 
differences in lipid profile, insulin and glucose levels were shown between the two 
groups. However, adiponectin concentrations were higher and Tumour Necrosis 
Factor-α and interleukin-1β levels were lower in TRE subjects than controls, at the end 
of the 8-week intervention.  
Orthodox fasters have been previously reported to present higher pre-fasting serum 
concentrations of the antioxidant factors retinol and a-tocopherol than non-fasting 
controls (Sarri et al. 2009). Our results failed to establish a significant impact of any of 
the two diets on systematic inflammation and glycaemic parameters. Yet, it should be 
noted that the present study included subjects with overweight, otherwise metabolically 
healthy, with normal baseline levels of hs-CRP, glucose and insulin. As a result, 
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significant changes of the aforementioned parameters in such a population and in a 
relatively short time period are difficult to be demonstrated.  
Our study presents several limitations. The small sample size and the short time period 
of the intervention, might have attenuated its power to reveal changes in the parameters 
investigated. Ideally, participants should have been randomised in the two arms. 
However, the adoption of religious fasting is closely related to the religious beliefs of 
each person and randomisation could not have been performed without violating these 
beliefs. The impact of physical activity on study results should be considered; yet, the 
fact that participants were asked to maintain a standard level of physical activity during 
the study might - in part – have counteracted the confounding effects of this parameter. 
Albeit hs-CRP levels contribute valuable information with respect to CV risk and 
mortality (Yousuf et al. 2013), the evaluation of alternative inflammation markers, such 
as serum adipokines and cytokines, would further enhance the validity of our results. 
Moreover, the method (BIA) used for body composition assessment was not the gold 
standard, since the measurements can be confounded by clinical status, such as the 
presence of oedema (Wells and Fewtrell, 2006).  
The OF group presented higher TG and lower HDL-C and ApoA concentrations than 
the TRE group at baseline. This is not unexpected, given that participants in the OF 
group have been following this dietary plan with great adherence for many consecutive 
years, for religious and spiritual reasons. Plant-based dietary patterns generally have a 
lipid-lowering effect that was evident among Orthodox fasters included in this study. 
On the other hand, it is also well established that the OF impact on lipids is not 
sustainable after the fasting cessation; an increase in TC and LDL-C levels, up to 6% 
and 9% respectively, has been observed when fasters return to their standard dietary 
habits (Koufakis et al. 2018). Finally, self-report dietary assessment data, although 
 19 
widely used in clinical nutrition research, might be challenged for accuracy (Archer et 
al. 2018). It should be noted however, that – at least for the OF group- this parameter 
might have a minimal impact on our results, since adherence to this dietary pattern is 
determined by long-standing religious beliefs of the participants. 
 
Conclusion 
In conclusion, the results of this small, pilot study suggest that OF and a hybrid model 
of CR and TRE exert comparable effects on BW. However, OF results in greater 
reductions of TC and atherogenic LDL-C concentrations than the TRE plan. The exact 
mechanisms mediating the impact of both diets on human health, are yet to be 
determined. Studies involving larger sample sizes and with longer follow-up periods 
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Table 1: Diet composition and macronutrients distribution at baseline and at the end of the study in both groups 
 
   Baseline                                                                End of study 
               OF (n=37) TRE (n=23)  OF (n=36)     TRE (n=22) 
 M SD  M SD       M       SD          M              SD  
Energy (kcal/day) 1535.5 176.3  1579.3 154.0 1648.5   278.3 1718.9        285.2 
Carbohydrates (kcal/day) 778.3 95.6  846.3 80.7 840.8 142.8 889.9         146.7 
Protein (kcal/day) 228.1 58.5  266.0 44.8 227.2 68.9 312.1          61.8 
Fat (kcal/day) 529.6 59.2  467.0 39.4 578.6 95.6 518.9          96.2 
% Carbohydrates 50.7 2.6  53.6 1.3 51.0 2.7 51.8            2.4 
% Protein 14.7 2.5  16.8 1.8 13.6 2.0 18.2            1.9 
% Fat 34.6 2.7  29.6 0.7 35.2 2.8 30.1            1.3 
% Saturated fat < 10 -  < 10 - < 10 -             < 10               - 
         
 
Values are presented as mean (M) ± standard deviation (SD). 
 











Table 2: Comparisons between features of Orthodox fasters before and after the fasting 
 
 





              Before (n=37)  After (n=36) 
    
 M SD  M SD p-value t d 
Weight (kg) 78.13 16.39  75.94 15.74 <.001 7.05 1.168 
BMI (kg/m2) 28.54 5.45  27.20 5.10 <.001 7.12 1.873 
Body Fat (%) 34.44 9.15  34.25 8.79 .844 .198 .033 
Body Fat (kg) 29.32 14.14  28.30 12.68 .186 1.42 .427 
Lean Body Mass (kg) 47.51 9.91  46.75 11.03 .362 1.23     .445 
Muscle Mass (kg) 48.80 9.76  47.94 10.84 .212 1.27 .212 
WC (cm) 91.10 13.88  90.30 13.91 .036 2.19 .372 
Hs-CRP (mg/dl) .24 .25  .23 .54 .885 .15 .017 
Fasting glucose (mg/dl) 84.23 7.96  85.17 9.53 .554 -.60 .101 
TC (mg/dl) 197.17 34.30  178.40 34.14 <.001 6.10 1.033 
TG (mg/dl) 102.80 45.54  108.59 74.63 .549 -.61 .102 
HDL-C (mg/dl) 53.91 12.31  51.01 11.66 .009 2.78 .470 
LDL-C (mg/dl) 122.37 29.70  105.89 28.08 <.001 5.98 1.010 
Apolipoprotein A (mg/dl) 146.79 23.70  142.56 23.42 .133 1.54 .264 
Apolipoprotein B (mg/dl) 98.44 27.01  96.73 26.60 .554 .60 .103 
Fasting Insulin (μΙU/ml) 10.08 7.46  9.98 9.00 .927 .09 .016 
HOMA-B 193.01 134.43  168.36 124.11 .293 1.07 .183 
HOMA-IR 2.14 1.69  2.12 1.98 .923 .097 .015 
 
Values are presented as mean (M) ± standard deviation (SD). Significant differences are presented in bold. 
 
Abbreviations: BMI: Body Mass Index; WC: Waist Circumference; Hs-CRP: High-sensitivity C-Reactive protein; TC: Total Cholesterol; TG: Triglycerides; 
HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; HOMA-B: homeostatic model assessment for beta-cell function; 
HOMA-IR: homeostatic model assessment for insulin resistance 
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Table 3: Comparisons between features of the TRE group before and after the diet 
 
    TRE group  
              Before (n=23)  After (n=22) 
   
 M SD  M SD p-value t d  
Weight (kg) 72.04 12.54  70.48 11.73 .001 3.70 .762  
BMI (kg/m2) 26.40 4.11  25.81 3.78 .001 3.83 .800  
Body Fat (%) 31.92 8.51  30.63 8.27 .055 2.03 .425  
Body Fat (kg) 23.05 7.61  22.01 7.32 .001 3.93 .811  
Lean Body Mass (kg) 50.54 12.77  49.06 15.57     .412     .897     .321  
Muscle Mass (kg) 48.76 9.85  48.49 9.61 .330 .995 .203  
WC (cm) 86.13 10.66  84.09 9.57 .009 2.85 .594  
Hs-CRP (mg/dl) .12 .11  .20 .25 .077 -1.87 .372  
Fasting glucose (mg/dl) 87.48 9.96  83.52 8.94 .087 1.79 .374  
TC (mg/dl) 201.26 28.41  197.09 29.61 .286 1.09 .228  
TG (mg/dl) 81.71 29.07  90.26 26.78 .036 -2.24 .467  
HDL-C (mg/dl) 64.04 16.72  60.13 15.93 .023 2.45 .510  
LDL-C (mg/dl) 120.87 28.74  118.87 26.84 .511 .67 .139  
Apolipoprotein A (mg/dl) 164.91 28.09  158.52 26.85 .140 1.53 .319  
Apolipoprotein B (mg/dl) 107.00 20.43  107.26 22.24 .902 -.13 .026  
Fasting Insulin (μΙU/ml) 11.33 16.01  8.08 4.88 .344 .97 .207  
HOMA-B 126.22 58.64  163.72 104.59 .059 -1.99 .541  
HOMA-IR 1.80 1.11  1.72 1.15 .781 .281 058  
 
Values are presented as mean (M) ± standard deviation (SD). Significant differences are presented in bold. 
 
Abbreviations: BMI: Body Mass Index; WC: Waist Circumference; Hs-CRP: High-sensitivity C-Reactive protein; TC: Total Cholesterol; TG: Triglycerides; 
HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; HOMA-B: homeostatic model assessment for beta-cell function; 




























Values are presented as mean (M) ± standard deviation (SD). Significant differences are presented in bold. 
Abbreviations: BMI: Body Mass Index; WC: Waist Circumference; Hs-CRP: High-sensitivity C-Reactive protein; TC: Total Cholesterol; TG: Triglycerides; 
HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; HOMA-B: homeostatic model assessment for beta-cell function; 
HOMA-IR: homeostatic model assessment for insulin resistance; OF: Orthodox fasting; TRE: Time restricted eating 
               Group  
                   OF (n=37)  TRE (n=23) 
    
 M SD  M SD  p-value      t      d 
Age (years) 50.11 8.66  46.43 9.2 0.128 - - 
Height (m) 1.65 .09  1.65 .09 0.799 - - 
Weight (kg) 78.13 16.39  72.04 12.54 .120 1.56 .4142 
BMI (kg/m2) 28.54 5.45  26.40 4.11 .098 1.68 .4461 
Body Fat (%) 34.44 9.15  31.92 8.51 .247 1.17 .3107 
Body Fat (kg) 29.32 14.14  23.05 7.61 .132 1.60 .5698 
Lean Body Mass (kg) 47.51 9.91  50.54 12.77 .341 1.32 .4567 
Muscle Mass (kg) 48.80 9.76  48.76 9.85 .989 -.014 .0037 
WC (cm) 91.10 13.88  86.13 10.66 .143 1.49 .3977 
Hs-CRP (mg/dl) .24 .25  .12 .11 .075 1.81 .4898 
Fasting glucose (mg/dl) 84.23 7.96  87.48 9.96 .221 -1.24 -.331 
TC (mg/dl) 197.17 34.30  201.26 28.41 .548 -.60 -.1602 
TG (mg/dl) 102.80 45.54  81.71 29.07 .026 2.28 .5953 
HDL-C (mg/dl) 53.91 12.31  64.04 16.72 .008 -2.77 -.7394 
LDL-C (mg/dl) 122.37 29.70  120.87 28.74 .945 .07 .0187 
Apolipoprotein A(mg/dl) 146.79 23.70  164.91 28.09 .008 -2.77 -.7394 
Apolipoprotein B (mg/dl) 98.44 27.01  107.00 20.43 .219 -1.243 -.3318 
Fasting Insulin (μΙU/ml) 10.08 7.46  11.33 16.01 .909 -.114 -.0304 
HOMA-B 193.01 134.43  126.22 58.64 .022 2.36 .63 
HOMA-IR 2.14 1.69  1.80 1.11 .209 1.27 .339 
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Table 5: Comparisons between features of the two groups after the diet 
 
   Group   
                  OF (n=36)  TRE (n=22) 
   
 M SD  M SD    p-value         t                         d 
Weight (kg) 75.94 15.74  70.48 11.73 .159 1.43 .3817 
BMI (kg/m2) 27.20 5.10  25.81 3.78 .110 1.62 .4324 
Body Fat (%) 34.25 8.79  30.63 8.27 .120 1.58 .4218 
Body Fat (kg) 28.30 12.68  22.01 7.32 .150 1.53 .5609 
Lean Body Mass (kg) 46.75 11.08  49.06 15.57 .301 1.44 .4765 
Muscle Mass (kg) 47.94 10.84  48.49 9.61 .848 -.193 -.051 
WC (cm) 90.30 13.91  84.09 9.57 .049 2.01 .5395 
Hs-CRP (mg/dl) .23 .54  .20 .25 .835 .21 .0571 
Fasting glucose (mg/dl) 85.17 9.53  83.52 8.94 .576 .56 .1496 
TC (mg/dl) 178.40 34.14  197.09 29.61 .028 -2.25 -.601 
TG (mg/dl) 108.59 74.63  90.26 26.78 .248 1.17 .3123 
HDL-C (mg/dl) 51.01 11.66  60.13 15.93 .013 -2.57 -.686 
LDL-C (mg/dl) 105.89 28.08  118.87 26.84 .067 -1.87 -.499 
Apolipoprotein A (mg/dl) 142.56 23.42  158.52 26.85 .019 -2.42 -.650 
Apolipoprotein B (mg/dl) 96.73 26.60  107.26 22.24 .106 -1.64 -.440 
Fasting Insulin (μΙU/ml) 9.98 9.00  8.08 4.88 .378 .889 .2419 
HOMA-B 168.36 124.11  163.72 104.59 .854 .185 .0501 
HOMA-IR 2.12 1.98  1.72 1.15 .415 .821 .2234 
 
Values are presented as mean (M) ± standard deviation (SD). Significant differences are presented in bold. 
 
Abbreviations: BMI: Body Mass Index; WC: Waist Circumference; Hs-CRP: High-sensitivity C-Reactive protein; TC: Total Cholesterol; TG: Triglycerides; 
HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; HOMA-B: homeostatic model assessment for beta-cell function; 
HOMA-IR: homeostatic model assessment for insulin resistance; OF: Orthodox fasting; TRE: Time restricted eating 
